A 2010 double-blind randomized clinical study of 28 patients with abdominal obesity found that after 12 sessions of ReduStim treatment over 6 weeks, patients experienced on average a 6.1 cm reduction in waist size. The treatment also led to a 23% reduction in ALAT liver enzymes and a 13% reduction in ASAT liver enzymes, proportionate to weight and abdominal fat loss. The conclusion was that fatty acids released from excess fat through the treatment were eliminated from the liver and body as CO2 and H2O rather than being restored in the liver.

1. 100% HANDS-FREE MEDICAL DEVICES
Bariatric surgeons • Obesity specialists
DECREASE VISCERAL FAT AND LIVER SIZE
DOUBLE-BLIND RANDOMIZED CLINICAL
STUDY (2010)
Dr Ghislaine Beilin, Dr Rodi Courie
Nutrition Unit - Endocrinologist – Pitié Salpêtrière Hospital
Evaluation of the average centimeter waist size reduction in 28 patients
with abdominal obesity after 12 sessions of ReduStim: -6.1 cm.
WWThe other 4 metabolic syndromes criteria remain unchanged.
WWFall of transaminases -23% ALAT & -13% ASAT in proportion to the drop
weight and abdominal fat.
Treatment of
12 x 45’ sessions
Diminution of
health risks
STUDY CONCLUSION:
Fatty acids released from the excess fat are not stored in the liver
but completely eliminated in CO2 and H2O.
IM
PR
O
V
E
B
A
R
IA
TR
IC
SU
R
G
ERY
Reduction of
visceral fat
BEFORE A BARIATRIC SURGERY:
Recommended protocol
12 sessions of 45 minutes (Daily)
AFTER A BARIATRIC SURGERY:
Recommended protocol
6 sessions of 45 minutes (2 times per week)
2 weeks after the surgery
Illustration of excess of abdominal fat
Illustration of fatty liver

2. REDUSTIM
BioStimology
+ Micropressure
REDUSTIM SP
BioStimology
(active or passive protocol)